InsiderDirector
Jean Jacques Bienaime Insider Trading Activity
Every SEC Form 4 transaction reported by Jean Jacques Bienaime, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Is Jean Jacques Bienaime buying or selling?
Jean Jacques Bienaime reported 15 open-market buys ($777.9K) and 79 sells ($70.4M) across 94 Form 4 filings at 6 companies — a net selling position of $69.7M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 17, 2026)
Total Form 4 filings
94
SEC EDGAR
Companies
6
Buys (15)
$777.9K
Sells (79)
$70.4M
Insider sentiment
Net sellingNet insider flow of $69.7M in net selling, filed between May 15, 2018 – Jul 17, 2026.
Companies Jean Jacques Bienaime files for
Recent Jean Jacques Bienaime transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Jul 17, 2026 | KROS | Director | Purchase | 1.0K | $10.6K |
| Jun 17, 2026 | KROS | Director | Purchase | 1.0K | $10.2K |
| Jun 1, 2026 | ASND | Director | Purchase | 500 | $111.6K |
| May 27, 2026 | ASND | Director | Purchase | 400 | $95.1K |
| May 19, 2026 | KROS | Director | Purchase | 1.0K | $10.6K |
| May 19, 2026 | IMNM | Director | Purchase | 5.0K | $103.5K |
| Apr 17, 2026 | KROS | Director | Purchase | 1.0K | $11.7K |
| Mar 12, 2026 | IMNM | Director | Purchase | 2.0K | $43.7K |
| Mar 11, 2026 | KROS | Director | Purchase | 2.0K | $22.4K |
| Jun 4, 2025 | IMNM | Director | Purchase | 5.0K | $46.9K |
| Mar 26, 2025 | IMNM | Director | Purchase | 7.8K | $60.7K |
| Mar 25, 2025 | IMNM | Director | Purchase | 7.0K | $57.5K |
| Aug 20, 2024 | IMNM | Director | Purchase | 7.0K | $97.6K |
| May 22, 2024 | IMNM | Director | Purchase | 2.0K | $27.1K |
| May 13, 2024 | BMRN | Director | Sale | 40.0K | $3.3M |
| Apr 15, 2024 | BMRN | Director | Sale | 40.0K | $3.6M |
| Mar 7, 2024 | BMRN | Director | Sale | 2.0K | $172.2K |
| Feb 29, 2024 | BMRN | Director | Sale | 1.0K | $90.3K |
| Feb 12, 2024 | BMRN | Director | Sale | 30.0K | $2.7M |
| Aug 9, 2023 | BMRN | Chief Executive Officer | Sale | 10.0K | $882.1K |
| May 15, 2023 | BMRN | Chief Executive Officer | Sale | 30.0K | $2.8M |
| Apr 10, 2023 | BMRN | Chief Executive Officer | Sale | 10.0K | $961.3K |
| Mar 14, 2023 | BMRN | Chief Executive Officer | Sale | 23.0K | $2.1M |
| Feb 15, 2023 | BMRN | Chief Executive Officer | Sale | 21.0K | $2.3M |
| Jan 19, 2023 | BMRN | Chief Executive Officer | Sale | 20.0K | $2.2M |
Showing the 25 most recent filings of 94. Screen every filing.
Jean Jacques Bienaime insider trading FAQ
Is Jean Jacques Bienaime buying or selling?
Across 94 SEC Form 4 filings, Jean Jacques Bienaime reported 15 open-market purchases totaling $777.9K and 79 sales totaling $70.4M — a net selling position of $69.7M.
Which companies does Jean Jacques Bienaime file Form 4s for?
Jean Jacques Bienaime has reported insider transactions at 6 companies, most often BIOMARIN PHARMACEUTICAL INC (BMRN), Immunome Inc. (IMNM), Keros Therapeutics, Inc. (KROS), INCYTE CORP (INCY), Ascendis Pharma A/S (ASND).
How far back does Jean Jacques Bienaime's filing history go?
Trabud holds Jean Jacques Bienaime's SEC Form 4 filings from May 15, 2018 – Jul 17, 2026, sourced directly from SEC EDGAR.
Where does Trabud get Jean Jacques Bienaime's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Jean Jacques Bienaime and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener